Acquisition Adds Significant Specialized Expertise to Decision Resources, Inc.’s Biopharma Offerings
January 19, 2010—Waltham, Mass. and Exton, Penn.—Decision Resources, Inc., one of the world’s leading research and advisory firms focusing on healthcare insights and analysis, announced today that it acquired BioTrends Research Group, the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets. The acquisition of Exton, Penn.-based BioTrends by Waltham, Mass.-based Decision Resources, Inc. will result in a significant expansion of Decision Resources, Inc.’s Portfolio Planning segment of the Biopharma business unit.
Jason LaBonte, Ph.D., newly appointed Chief Operating Officer, Biopharma Portfolio Planning and Optimization said, “This important acquisition expands the breadth of our disease coverage. BioTrends’ deep clinical intimacy with specialized pharmaceutical markets and primary research-focused model enhances our high-value offerings to the biopharma industry.”
BioTrends is particularly well-known in the nephrology market, offering unique insights on drugs in that market. They also cover dermatology, gastroenterology, immunology/infectious disease and rheumatology markets and, as the newest company in the Decision Resources, Inc. portfolio, plan to expand their coverage of diseases.
“We are excited to begin our next wave of growth as a Decision Resources, Inc. company,” said Jennifer Robinson, president of BioTrends. “We bring to the table an emphasis on quality and a level of detail in our syndicated research that is second-to-none.”
BioTrends will remain headquartered in Exton, Penn.
About BioTrends Research Group, Inc.
BioTrends Research Group, Inc. provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For more information, please visit www.Bio-Trends.com.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed, knowledgeable decisions. With over 450 employees worldwide, analysts at Decision Resources, Inc. companies provide the pharmaceutical, biotech, medical device, financial services and managed care industries with the analytics they need to compete and thrive in an increasingly competitive marketplace. Through both organic growth and an aggressive acquisition strategy, Decision Resources, Inc. has become the premier provider of healthcare analysis and data in the world. Visit Decision Resources, Inc. at www.DecisionResourcesInc.com.
For more information, contact:
Decision Resources, Inc.
Return to Press Releases